Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HAEMONETICS CORP Director's Dealing 2018

Jun 12, 2018

31565_dirs_2018-06-12_c1f90231-fad1-43c8-8afa-82f01112e653.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2018-06-08

Reporting Person: Goldstein Dan (VP, Corporate Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-06-08 Common Stock S 578 $92.90 Disposed 3022 Direct

Footnotes

F1: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2018.

F2: This number includes unvested restricted stock units previously reported.